prof. dr hab. Agnieszka Basta-Kaim

prof. dr hab. Agnieszka Basta-Kaim

+48 12 6623273
pokój 49
Zakład Neuroendokrynologii Doświadczalnej

Dokonania naukowe

  • Publikacje

Adverse Childhood Experiences Predict the Phenome of Affective Disorders and These Effects Are Mediated by Staging, Neuroimmunotoxic and Growth Factor Profiles

Autorzy: Michael Maes, Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, Siriwan Klinchanhom, Monojit Debnath, Agnieszka Basta-Kaim, Marta Kubera, Abbas F. Almulla, Atapol Sughondhabirom

DOI: 10.3390/cells11091564
Date: 2022-05-01

Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways

Autorzy: Kinga Tylek, Ewa Trojan, Monika Leśkiewicz, Magdalena Regulska, Natalia Bryniarska, Katarzyna Curzytek, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim

DOI: 10.3390/cells10092373
Date: 2021-09-01

The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures

Autorzy: Ewa Trojan, Kinga Tylek, Monika Leśkiewicz, Władysław Lasoń, Lars-Ove Brandenburg, Marcello Leopoldo, Enza Lacivita, Agnieszka Basta-Kaim

DOI: 10.3390/cells10061524
Date: 2021-06-01

The emerging role of mechanical and topographical factors in the development and treatment of nervous system disorders: dark and light sides of the force

Autorzy: Bryniarska-Kubiak, N., Kubiak, A., Lekka, M., Basta-Kaim, A.

DOI: 10.1007/s43440-021-00315-2
Date: 2021-01-01

Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology

Autorzy: Tylek, K., Trojan, E., Regulska, M., Lacivita, E., Leopoldo, M., Basta-Kaim, A.

DOI: 10.1007/s43440-021-00271-x
Date: 2021-01-01

The emerging role of the double-edged impact of arachidonic acid-derived eicosanoids in the neuroinflammatory background of depression

Autorzy: Regulska, M., Szuster-Głuszczak, M., Trojan, E., Leśkiewicz, M., Basta-Kaim, A.

DOI: 10.2174/1570159X18666200807144530
Date: 2021-01-01

Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia

Autorzy: Chamera, K., Szuster-Głuszczak, M., Basta-Kaim, A.

DOI: 10.1007/s43440-021-00269-5
Date: 2021-01-01

Stiffening of DU145 prostate cancer cells driven by actin filaments-microtubule crosstalk conferring resistance to microtubule-targeting drugs

Autorzy: Kubiak, A., Chighizola, M., Schulte, C., Bryniarska, N., Wesolowska, J., Pudelek, M., Lasota, M., Ryszawy, D., Basta-Kaim, A., Laidler, P., Podestà, A., Lekka, M.

DOI: 10.1039/d0nr06464e
Date: 2021-01-01

Mitochondria-targeting therapeutic strategies in the treatment of depression

Autorzy: Głombik, K., Budziszewska, B., Basta-Kaim, A.

DOI: 10.1016/j.mito.2021.03.006
Date: 2021-01-01

The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1–42)-Induced Neuroinflammation in Mouse Models of Alzheimer’s Disease

Autorzy: Trojan, E., Tylek, K., Schröder, N., Kahl, I., Brandenburg, L.-O., Mastromarino, M., Leopoldo, M., Basta-Kaim, A., Lacivita, E.

DOI: 10.1007/s12035-021-02543-2
Date: 2021-01-01

Zobacz także